2-氨基-N-[2-(1-苄基哌啶-4-基)乙基]乙酰胺 | 757236-89-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 2-氨基-N-[2-(1-苄基哌啶-4-基)乙基]乙酰胺
• 英文名称: 2-Amino-N-[2-(1-benzyl-piperidin-4-yl)-ethyl]-acetamide
• 英文别名: N-[2-(1-Benzylpiperidin-4-yl)ethyl]glycinamide；2-amino-N-[2-(1-benzylpiperidin-4-yl)ethyl]acetamide
• CAS: 757236-89-8
• 化学式: C₁₆H₂₅N₃O
• 分子量: 275.394
• InChiKey: QYDORGKNURUUNY-UHFFFAOYSA-N

物化性质

• 沸点：
  456.7±25.0 °C(Predicted)
• 密度：
  1.075±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  20
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  58.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3,4-二甲氧基苯甲酰氯 、 2-氨基-N-[2-(1-苄基哌啶-4-基)乙基]乙酰胺 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 以82%的产率得到N-{[2-(1-Benzyl-piperidin-4-yl)-ethylcarbamoyl]-methyl}-3,4-dimethoxy-benzamide
  参考文献：
  名称：

  Synthesis and evaluation of tacrine–E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease

  摘要：

  Tacrine-E2020 hybrids and some related compounds were prepared and their bioactivities on the Alzheimer's disease were assayed. The optimum hybrid inhibitor 3 is 37-fold more potent and 31-fold more selective than tacrine in vitro. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.07.005
• 作为产物：
  描述：

  2-(1-苄基-4-哌啶)乙腈 在 lithium aluminium tetrahydride 、 三氟乙酸 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 生成 2-氨基-N-[2-(1-苄基哌啶-4-基)乙基]乙酰胺
  参考文献：
  名称：

  Synthesis and evaluation of tacrine–E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease

  摘要：

  Tacrine-E2020 hybrids and some related compounds were prepared and their bioactivities on the Alzheimer's disease were assayed. The optimum hybrid inhibitor 3 is 37-fold more potent and 31-fold more selective than tacrine in vitro. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.07.005

文献信息

• Synthesis and evaluation of tacrine–E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease
  作者：Dong Shao、Chunyan Zou、Cheng Luo、Xican Tang、Yuanchao Li

  DOI：10.1016/j.bmcl.2004.07.005

  日期：2004.9

  Tacrine-E2020 hybrids and some related compounds were prepared and their bioactivities on the Alzheimer's disease were assayed. The optimum hybrid inhibitor 3 is 37-fold more potent and 31-fold more selective than tacrine in vitro. (C) 2004 Elsevier Ltd. All rights reserved.